Schonfeld Strategic Advisors LLC Arcturus Therapeutics Holdings Inc. Call Options Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$12.26 - $31.17 $545,570 - $1.39 Million	-44,500 Reduced 16.18%	230,500 $3.63 Million
Q4 2021 Feb 14, 2022	BUY	$34.2 - $47.56 $7.7 Million - $10.7 Million	225,000 Added 450.0%	275,000 $10.2 Million
Q3 2020 Nov 19, 2020	SELL	$37.49 - $63.19 $186 Million - $313 Million	-4,950,000 Reduced 99.0%	50,000 $2.15 Million
Q3 2020 Nov 16, 2020	BUY	$37.49 - $63.19 $187 Million - $316 Million	5,000,000 New	5,000,000 $2.15 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $450M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.